References
Kronzon I, Saric M. Cholesterol embolization syndrome. Circulation 2010; 122: 631–41.
Avci G, Akoz T, Gul AE. Cutaneous cholesterol embolization. J Dermatol Case Rep 2009; 3: 27–9.
Falanga V, Fine MJ, Kapoor WN. The cutaneous manifestations of cholesterol crystal embolization. Arch Dermatol 1986; 122: 1194–8.
Bohlen P, Baird A, Esch F, et al. Isolation and partial molecular characterization of pituitary fibroblast growth factor. Proc Natl Acad Sci USA 1984; 81: 5364–8.
Akita S, Akino K, Imaizumi T, et al. Basic fibroblast growth factor accelerates and improves second-degree burn wound healing. Wound Repair Regen 2008; 16: 635–41.
Kobayashi H, Abe M, Murata Y, et al. Low-density lipoprotein apheresis for corticosteroid-resistant skin lesions caused by cholesterol crystal embolism: a case report and review of the literature. J Artif Organs 2015; 18: 285–9.
Erfurt-Berge C, Dissemond J, Schwede K, et al. Updated results of 100 patients on clinical features and therapeutic options in necrobiosis lipoidica in a retrospective multicentre study. Eur J Dermatol 2015; 25: 595–601.
Ramirez H, Patel SB, Pastar I. The role of TGFβ signaling in wound epithelialization. Adv Wound Care (New Rochelle) 2014; 3: 482–91.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Takeichi, T., Akiyama, M. Successful treatment of a cutaneous ulcer due to cholesterol crystal embolization with topical basic fibroblast growth factor. Eur J Dermatol 27, 182–183 (2017). https://doi.org/10.1684/ejd.2016.2920
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2016.2920